F.i.s. Fabbrica Italiana Sintetici

VISIT THE VIRTUAL BOOTH, Contact Details

DIGITAL CONTENT

Interview #SpeakPharma, Vlog #PharmaReel, Data Compilation #PharmaFlow, 2 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

186 All APIs, 85 USDMF, 40 CEP/COS, 22 JDMF, 32 KDMF, 121 NDC API, 5 VMF, 3 Listed APIs

INSPECTIONS & REGISTRATIONS

5 FDA, 3 EDQM, 3 GDUFA

Filters

Digital content

Create Content with PharmaCompass, ask us

INTERVIEW #SpeakPharma

[Sponsored by another company]

Alchem NicSelect™ grants customers royalty-free access to T-MAX™ tech for 3-in-1 vape satisfaction in flavour-restricted markets

With increasing flavour bans in key markets, vaping brands are facing significant challenges in providing satisfying alternatives to vapers and smokers looking to transition. Recognising this need, Alchem NicSelect™ is making a bold move by offering its key customers royalty-free and unrestricted geographical access to its revolutionary T-MAX™ technology.“At Alchem NicSelect™, we understand the urgency for vaping brands to adapt to new regulations without compromising on satisfaction. By offering royalty-free access to T-MAX™ technology, we empower our customers to provide the closest cigarette-like experience possible, even in markets with strict flavour restrictions,” said Riccardo Santambrogio, Europe Sales Manager.HIGHLIGHTS// offering royalty-free access to T-MAX™ technology/ unrestricted geographical access/ closest cigarette-like experience Addressing the biggest barrier: Nicotine satisfactionOne of the primary reasons many vapers are dissatisfied and smokers struggle to switch to vaping is that traditional nicotine solutions fail to replicate the rapid satisfaction provided by cigarettes. Nicotine replacement therapies (NRTs) and even conventional vaping products often lack the immediate nicotine hit, throat feel, and overall experience that smokers are accustomed to. T-MAX™ solves this problem by engineering a nicotine experience that closely mimics cigarette consumption without relying on flavours.T-MAX™ provides a unique 3-in-1 approach:1. The Speed of a Cigarette – Rapid nicotine delivery and rush within seconds for immediate satisfaction.2. The Power of Nicotine Salts – A stronger perceived nicotine effect without exceeding legal limits (20 mg/ml nicotine limit under the European Tobacco Products Directive). With T-MAX™, 8 mg/ml feels like 20 mg/ml, and 14 mg/ml feels like 40 mg/ml.3. The Throat Hit of Freebase Nicotine – Especially in a flavour-free formulation, the combined ingredients in T-MAX™ deliver an even more satisfying throat feel than expected from nicotine base, much closer to and more familiar with a cigarette throat feel that habitual smokers recognise.HIGHLIGHTS// unique 3-in-1 approach/ rush within seconds/ stronger perceived nicotine effect without exceeding legal limits/ more satisfying throat feel that habitual smokers recogniseNo flavour, but not less satisfyingWhile flavours have traditionally played a role in vaping adoption, market realities are shifting. With flavour bans spreading across regions, brands need solutions that deliver satisfaction without relying on taste. Consumer research has shown that T-MAX™ performs exceptionally well even without added flavours. Since most cigarette smokers do not smoke for the tobacco flavour but rather for the nicotine hit and habitual experience, T-MAX™ provides a viable alternative that aligns with new regulatory landscapes.HIGHLIGHTS// flavour bans spreading across regions/ T-MAX™ performs exceptionally well even without added flavoursEmpowering vape brands with free access to T-MAX™By granting customers royalty-free access to the T-MAX™ technology, Alchem NicSelect™ is removing barriers for vaping brands and original equipment manufacturers (OEMs) looking to adapt to regulatory changes. This open-access approach ensures that manufacturers can integrate T-MAX™ into their product lines without additional costs, allowing them to offer superior nicotine satisfaction in markets where flavours are no longer an option.HIGHLIGHTS// removing barriers for vaping brands and OEMs looking to adapt/ manufacturers can integrate T-MAX™ into product lines without additional costsThe future of vaping in restricted marketsWith T-MAX™, the vaping industry has a powerful tool to retain customers and convert smokers who have struggled with traditional vaping products. By delivering the key elements of cigarette satisfaction — without combustion or flavours — T-MAX™ is set to redefine what a satisfying vape experience means in a post-flavour-ban world.“Our commitment to innovation and accessibility means we are providing our customers with the solutions they need to navigate an evolving regulatory landscape. T-MAX™ allows brands to offer a highly satisfying experience that mimics smoking without relying on flavours. The message is clear: no flavour, but not less satisfying”, added Santambrogio.HIGHLIGHTS// powerful tool to retain customers and convert smokers/ delivering the key elements of cigarette satisfaction without combustion or flavours/ no flavour, but not less satisfying

Impressions: 1235

VLOG #PharmaReel

[Sponsored by another company]

Providing RSMs & API to Global Pharma Companies

This PharmaReel showcases Allsino Pharmaceutical, a company that provides GMP-certified RSMs and APIs to global pharma companies, specializing in peptides, oligonucleotides, and small molecule CDMO services. Allsino has a presence in the US, EU, China and Japan.

Impressions: 1215

DATA COMPILATION #PharmaFlow

[Sponsored by another company]

J&J’s Intra‑Cellular buyout, BMS’ oncology gambit, Sanofi’s Blueprint acquisition drive mega deals in H1 2025

The pharmaceutical industry has witnessed a wave of mergers, acquisitions, and strategic partnerships so far in the first half (H1) of 2025, with deal values exceeding US$ 170 billion.PharmaCompass’ data shows oncology alone accounted for nearly US$ 47 billion in deal value, followed by US$ 18 billion each in immunology and psychiatry, US$ 17 billion in nutrition/weight loss and US$ 7 billion in neurology.Pharma majors such as Johnson & Johnson and Bristol Myers Squibb led with two deals worth over US$ 10 billion each. Sanofi executed a series of deals in the immunology and neuro-inflammation space. And Eli Lilly stood out for its aggressive dealmaking, which spanned oncology, pain, RNA therapies, and AI-driven oligonucleotides. In all, it signed seven deals worth over US$ 1 billion each. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available)H1 records several mega deals as J&J buys Intra-Cellular, BMS ties up with BioNTech, Sanofi acquires BlueprintJohnson & Johnson dominated headlines with its US$ 14.6 billion acquisition of Intra-Cellular Therapies in January 2025. This marks the largest biopharma deal since Novo Nordisk’s US$ 16.5 billion acquisition of Catalent in February 2024. This acquisition positions J&J as a formidable player in the neuroscience space. Bristol Myers Squibb entered into a US$ 11.1 billion partnership with BioNTech. The deal structure — US$ 3.5 billion in unconditional payments and up to US$ 7.6 billion in milestone payments — demonstrates BMS’ confidence in BNT327, a next-generation bispecific antibody in phase 3 trials for treating extensive stage small cell lung cancer and non-small cell lung cancer.Sanofi acquired Blueprint Medicines for US$ 9.5 billion in order to enhance its rare disease portfolio. The French drugmaker is also creating a comprehensive immunology portfolio. The company signed a US$ 1.9 billion deal for Dren Bio’s DR-0201 bispecific antibody for autoimmune diseases. Sanofi also acquired Vigil Neuroscience for US$ 470 million for its phase 2-ready Alzheimer’s disease candidate. Additionally, the drugmaker secured a US$ 1.84 billion global license agreement with Earendil Labs for two next-generation bispecific antibodies.Pfizer’s US$ 6.05 billion partnership with 3SBio provides it global licensing rights (excluding China) for SSGJ-707, a bispecific antibody currently undergoing multiple clinical trials in China for non-small cell lung cancer, metastatic colorectal cancer, and gynecological tumors. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available) Obesity gold rush sees Roche, AbbVie, Sciwind ink deals; Novo pledges over US$ 5 bn across three dealsThe obesity therapeutics market has triggered intense competition among pharmaceutical giants. Roche’s US$ 5.3 billion partnership with Zealand Pharma is focused on petrelintide, an amylin analog designed to preserve lean mass better than existing GLP-1-based treatments. The collaboration combines petrelintide with Roche’s dual GLP-1/GIP receptor agonist CT-388, creating a differentiated obesity treatment.Market leader Novo Nordisk has promised over US$ 5 billion across three major obesity deals in 2025. The US$ 2.2 billion Septerna collaboration targets oral small molecule medicines for obesity and cardiometabolic diseases.Novo signed a separate US$ 2 billion agreement with China’s United Biotechnology for UBT251, a triple agonist for GLP-1, GIP, and glucagon receptors in phase 2 clinical development for obesity, type 2 diabetes, and other diseases. The company’s third major deal, a US$ 1 billion partnership with Lexicon Pharmaceuticals, provides it access to LX9851, a molecule in preclinical development for obesity and associated metabolic disorders.Sciwind Biosciences secured a US$ 2.5 billion global licensing and collaboration agreement with Verdiva Bio Limited for the global development and commercialization of a portfolio of metabolic diseases therapies. AbbVie entered the amylin arena through its US$ 2.2 billion Gubra partnership for GUB014295, a candidate in phase 1 trials for treating obesity. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available) Molecular glue degraders draw investments; Lilly signs seven deals over US$ 1 billion eachMolecular glue degraders have emerged as a transformative therapeutic modality, attracting significant investment across multiple partnerships. AbbVie’s US$ 1.64 billion collaboration with Neomorph leverages the biotech’s leading molecular glue discovery platform for oncology and immunology applications.Genentech’s potential US$ 2.1 billion partnership with Orionis Biosciences focuses on small-molecule monovalent glue medicines for novel and challenging oncology targets. This is the second partnership between the two companies, following their initial 2023 collaboration.Eli Lilly has collaborated with Magnet Biomedicine, utilizing Magnet’s TrueGlue discovery platform for oncology applications. The deal could be worth up to US$ 1.3 billion.Eli Lilly has emerged as one of 2025’s most active dealmakers, with approximately seven deals exceeding US$ 1 billion each. The company’s US$ 2.5 billion Scorpion Therapeutics acquisition provides access to STX-478, an experimental oral therapy in early-stage trials for breast cancer and advanced solid tumors, potentially addressing 30 to 40 percent of hormone-positive breast cancer patients.On June 17, Lilly announced the acquisition of gene-editing startup Verve Therapeutics for US$ 1.3 billion. Lilly’s US$ 1 billion SiteOne acquisition announced in May brings STC-004, a phase 2-ready non-opioid chronic pain treatment to its pipeline. Other partnerships announced by Lilly include a US$ 1.4 billion capsid licensing deal with Sangamo for central nervous system disease genomic medicines and a US$ 1.3 billion collaboration with South Korean company Rznomics for RNA-based hearing loss treatments. Lilly has also strengthened its oligonucleotide pipeline through a potential US$ 1 billion collaboration with Creyon Bio for AI-designed oligonucleotide therapies targeting RNA. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available) Merck KGaA acquires SpringWorks for US$ 3.9 bn; Novartis buys out Anthos for US$ 3.1 bnAstraZeneca signed a US$ 5.3 billion AI-led research agreement with China’s CSPC Pharmaceuticals Group to advance the discovery of novel oral candidates for immunological diseases. Merck KGaA acquired SpringWorks for US$ 3.9 billion in April, which gave it access to two FDA-approved therapies — Ogsiveo (nirogacestat), the first and only approved therapy for adult patients with progressing desmoid tumors requiring systemic treatment, and Gomekli (mirdametinib), the first and only FDA-approved therapy for adults and children with neurofibromatosis type 1-associated plexiform neurofibromas.Novartis’ US$ 3.1 billion Anthos Therapeutics acquisition centered around abelacimab, a potential first-in-class monoclonal antibody currently in three phase 3 studies for stroke and systemic embolism prevention in atrial fibrillation patients.GSK’s US$ 2 billion acquisition of Boston Pharmaceuticals’ efimosfermin targets steatotic liver disease (fatty liver disease). The medicine is also in clinical development for MASH treatment. GSK’s second major deal involved the US$ 1.15 billion acquisition of US biotech IDRx, strengthening its gastrointestinal cancer portfolio.The pharma industry also drew some private equity interest as Bain Capital acquired Japan’s Mitsubishi Tanabe Pharma from Mitsubishi Chemical Group for US$ 3.3 billion. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available) Our viewDespite an uncertain geopolitical environment, the year has seen a surge in M&As and dealmaking in the first half of 2025. However, a sizable chunk of the acquisitions were bolt-on transactions, indicating that companies are not ready to take on risks, and are buying out smaller players who strategically fit into their operations. Going forward, there are indications that M&A activity will stay strong throughout 2025.

Impressions: 2783

NEWS #PharmaBuzz

[Sponsored by another company]

Fabbrica Italiana Sintetici (F.I.S.) Selects Kinaxis for Supply Chain Planning

22 Aug 2023

// BUSINESSWIRE

India woos Italian bulk drug makers to cut dependency on Chinese APIs

13 Aug 2015

// Raji Reddy Kesireddy THE ECONOMIC TIMES

Contact F.i.s. Fabbrica Italiana Sintetici and get a quotation

F.i.s. Fabbrica Italiana Sintetici is a supplier offers 146 products (APIs, Excipients or Intermediates).

Find a price of Chlordiazepoxide bulk with DMF, CEP, JDMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Clonazepam bulk with DMF, CEP, JDMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Clotrimazole bulk with DMF, CEP, JDMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Diazepam bulk with DMF, CEP, JDMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Furosemide bulk with DMF, CEP, JDMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Lorazepam bulk with DMF, CEP, JDMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Rifaximin bulk with DMF, CEP, JDMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Dorzolamide Hydrochloride bulk with CEP, JDMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Acetylcysteine bulk with DMF, CEP offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Bromazepam bulk with CEP, JDMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Carbamazepine bulk with DMF, CEP offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Clomiphene Citrate bulk with DMF, JDMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Diltiazem Hydrochloride bulk with DMF, CEP offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Esomeprazole Magnesium bulk with DMF, CEP offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Flurazepam bulk with DMF, JDMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Fosfomycin Trometamol bulk with DMF, CEP offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Gabapentin bulk with DMF, CEP offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Imatinib Mesylate bulk with DMF, CEP offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Indomethacin bulk with DMF, CEP offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Midazolam bulk with CEP, JDMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Nifedipine bulk with DMF, CEP offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Nitrazepam bulk with CEP, JDMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Nitrofurantoin bulk with DMF, CEP offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Oxazepam bulk with DMF, CEP offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Oxcarbazepine bulk with DMF, CEP offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Pentazocine bulk with DMF, JDMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Progesterone bulk with DMF, CEP offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Quetiapine Hemifumarate bulk with DMF, JDMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Sulindac bulk with DMF, JDMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Entacapone bulk with DMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Olopatadine Hydrochloride bulk with JDMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Oxcarbazepine bulk with CEP offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Prazepam bulk with CEP offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Testosterone Propionate bulk with DMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Bazedoxifene bulk with DMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Chlordiazepoxide bulk with CEP offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Chlordiazepoxide HCl bulk with CEP offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Clobazam bulk with DMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Clomiphene Citrate bulk with DMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Dorzolamide Hydrochloride bulk with DMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Eletriptan Hydrobromide bulk with DMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Erlotinib Hydrochloride bulk with DMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Esomeprazole Magnesium bulk with DMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Estazolam bulk with DMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Flunitrazepam bulk with CEP offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Flurazepam Monohydrochloride bulk with CEP offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Fluvastatin Sodium bulk with JDMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Imatinib Mesylate bulk with DMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Indomethacin Sodium bulk with DMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Lansoprazole bulk with JDMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Midazolam Hydrochloride bulk with DMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Nebivolol bulk with DMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Nilotinib bulk with DMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Nitrofurantoin bulk with DMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Olopatadine Hydrochloride bulk with DMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Prasterone Acetate bulk with DMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Propofol bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Safinamide Methanesulfonate bulk with DMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Sitagliptin Phosphate bulk with JDMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Temazepam bulk with DMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Testosterone Cypionate bulk with DMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Tramazoline Hydrochloride Monohydrate bulk with CEP offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of ENAMINE AMIDE (FIS0448) bulk with DMF offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Oxcarbazepine, Code 1138 milled grade bulk with CEP offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Nebivolol hydrochloride, Micronised bulk with CEP offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of 2,5-Dibromo-1,4-Dimethyl-1H-Imidazole bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of 4-Des-Dimethylaminotetracycline bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Allopurinol bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Benzylhydrazine bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Clobazam bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Clorazepate Dipotassium bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Desipramine Hydrochloride bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Diltiazem Hydrochloride bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Esomeprazole Magnesium bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Flunitrazepam bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Furazolidone bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Piroxicam bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Quazepam bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Quetiapine Hemifumarate bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Solifenacin Succinate bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Terbinafine bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Tetrazepam bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Triamterene bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Trimethobenzamide HCl bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Trimethoprim bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN ALTE DI MONTECCHIO MAGGIORE. bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of FIS0127 bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of CALCIUM CHANNEL BLOCKER - RO 40-5967/001 bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Armodafinil bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Ataluren bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Bazedoxifene Acetate bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Carbamazepine bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of CAS 654671-77-9 bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Chlordiazepoxide bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Clomiphene Citrate bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Clotrimazole bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Darifenacin Hydrobromide bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Delorazepam bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Diazepam bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Doravirine bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Edoxaban Tosylate bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Efavirenz bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Eletriptan Hydrobromide bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Elvitegravir bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Entacapone bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Estradiol bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Etoricoxib bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Febuxostat bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Finasteride bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Fluralaner bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Fosaprepitant bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Furosemide bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Gabapentin bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Indomethacin bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Ivabradine Hydrochloride bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Lapatinib Ditosylate bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Levothyroxine Sodium bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Marbofloxacin bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Midazolam Maleate bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Mycophenolate Mofetil bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Nelarabine bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Nifedipine bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Nitrofurantoin bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Olopatadine Hydrochloride bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Omecamtiv Mecarbil bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Oxcarbazepine bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Pazopanib Hydrochloride bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Perampanel bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Procarbazine Hydrochloride bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Progesterone bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Ranolazine bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Sitagliptin Phosphate bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Sofosbuvir bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Sotagliflozin bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Sugammadex Sodium bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Sumatriptan bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Temazepam bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Terbinafine Hydrochloride bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Testosterone bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Testosterone Enanthate bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Testosterone Undecanoate bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Trofinetide bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Ulotaront bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Valbenazine Tosylate bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Velpatasvir bulk offered by F.i.s. Fabbrica Italiana Sintetici

Find a price of Vildagliptin bulk offered by F.i.s. Fabbrica Italiana Sintetici